Holdings of Soleus Capital Management, L.P.
82 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 55.3 % of the equity sleeve
Sector breakdown
- Health care 10.1 %
- Unattributed 89.9 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 98.6 %
- FR 1.3 %
- NL 0.1 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|
| US | 80 | 2.1B $ | 98.61 % |
| FR | 1 | 27.2M $ | 1.27 % |
| NL | 1 | 2.6M $ | 0.12 % |
Positions
| Company | Shares | Value | Weight |
|---|
| Krystal Biotech Inc | 1,153,087 | 297.9M $ | |
| Celcuity Inc | 1,284,378 | 146.6M $ | |
| TG Therapeutics Inc | 4,029,319 | 133.9M $ | |
| Insulet Corp | 562,500 | 118M $ | |
| United Therapeutics Corp | 187,187 | 111M $ | |
| Praxis Precision Medicines Inc | 330,517 | 106.5M $ | |
| Vericel Corp | 2,549,079 | 82M $ | |
| ANI Pharmaceuticals Inc | 820,243 | 63.1M $ | |
| Globus Medical Inc | 729,467 | 62.9M $ | |
| Geron Corp | 41,508,659 | 61.8M $ | |
| Twist Bioscience Corp | 1,226,629 | 58.3M $ | |
| Edgewise Therapeutics Inc | 1,449,915 | 45.7M $ | |
| Beta Bionics Inc | 4,354,501 | 43.6M $ | |
| Alnylam Pharmaceuticals Inc | 131,650 | 43.6M $ | |
| Syndax Pharmaceuticals Inc | 1,726,908 | 40.3M $ | |
| Indivior Pharmaceuticals Inc | 1,274,000 | 38.8M $ | |
| NeuroPace Inc | 2,932,207 | 38.6M $ | |
| Mirum Pharmaceuticals Inc | 400,306 | 37M $ | |
| BioMarin Pharmaceutical Inc | 650,572 | 36.8M $ | |
| Progyny Inc | 2,067,000 | 35.1M $ | |
| Inspire Medical Systems Inc | 576,299 | 29.7M $ | |
| Edap Tms SA | 7,309,254 | 27.2M $ | |
| Merck & Co Inc | 203,000 | 24.4M $ | |
| Organogenesis Holdings Inc | 10,085,951 | 23.9M $ | |
| Natera Inc | 119,000 | 23.8M $ | |
| Axogen Inc | 679,170 | 22.5M $ | |
| Vaxcyte Inc | 385,472 | 22.4M $ | |
| Cerus Corp | 10,753,700 | 19.6M $ | |
| Trevi Therapeutics Inc | 1,620,000 | 19.3M $ | |
| Inhibikase Therapeutics Inc | 10,875,000 | 18.3M $ | |
| Context Therapeutics Inc | 6,963,141 | 18.2M $ | |
| Vir Biotechnology Inc | 2,002,000 | 17.9M $ | |
| Travere Therapeutics Inc | 546,000 | 16.2M $ | |
| Tandem Diabetes Care Inc | 783,000 | 15M $ | |
| Nurix Therapeutics Inc | 938,163 | 14.5M $ | |
| Sionna Therapeutics Inc | 293,500 | 11.8M $ | |
| Corcept Therapeutics Inc | 285,531 | 11.5M $ | |
| JADE BIOSCIENCES INC | 796,744 | 11.2M $ | |
| Veracyte Inc | 319,912 | 10.3M $ | |
| Invivyd Inc | 7,708,727 | 10M $ | |
| C4 Therapeutics Inc | 3,803,942 | 10M $ | |
| OrthoPediatrics Corp | 615,447 | 9.8M $ | |
| Arcus Biosciences Inc | 451,983 | 9.8M $ | |
| Tango Therapeutics Inc | 450,000 | 9.4M $ | |
| Evolus Inc | 2,245,360 | 9.2M $ | |
| Enliven Therapeutics Inc | 230,869 | 9.1M $ | |
| Inhibrx Biosciences Inc | 131,000 | 8.8M $ | |
| Dexcom Inc | 140,000 | 8.8M $ | |
| Septerna Inc | 275,000 | 6.6M $ | |
| AVALO THERAPEUTICS INC | 441,978 | 6.6M $ | |
| BIODESIX INC | 416,599 | 6M $ | |
| Relmada Therapeutics Inc | 842,106 | 5.9M $ | |
| Cullinan Therapeutics Inc | 410,200 | 5.8M $ | |
| Immunovant Inc | 230,000 | 5.7M $ | |
| MBX Biosciences Inc | 178,897 | 5.3M $ | |
| IMMUNIC INC | 4,500,000 | 5M $ | |
| Larimar Therapeutics Inc | 1,066,960 | 4.8M $ | |
| Eton Pharmaceuticals Inc | 166,381 | 4.1M $ | |
| SAB Biotherapeutics Inc | 1,050,000 | 4M $ | |
| PROCEPT BIOROBOTICS CORP | 160,000 | 4M $ | |
| Structure Therapeutics Inc | 80,000 | 3.9M $ | |
| Tectonic Therapeutic Inc | 121,684 | 3.8M $ | |
| Pulmonx Corp | 2,788,323 | 3.6M $ | |
| Iovance Biotherapeutics Inc | 1,000,000 | 3.5M $ | |
| Argenx SE | 3,500 | 2.6M $ | |
| Karyopharm Therapeutics Inc | 440,000 | 2.5M $ | |
| Arrowhead Pharmaceuticals Inc | 28,479 | 1.8M $ | |
| InspireMD, Inc. | 1,045,708 | 1.7M $ | |
| Insmed Inc | 10,250 | 1.7M $ | |
| CytomX Therapeutics Inc | 300,000 | 1.4M $ | |
| CG oncology Inc | 20,000 | 1.4M $ | |
| NeoGenomics Inc | 175,000 | 1.3M $ | |
| Cogent Biosciences Inc | 10,000 | 384.9K $ | |
| Tyra Biosciences Inc | 10,000 | 383K $ | |
| STAAR Surgical Co | 20,000 | 374K $ | |
| AnaptysBio Inc | 6,000 | 332.8K $ | |
| Rapport Therapeutics Inc | 10,000 | 312.9K $ | |
| Rigel Pharmaceuticals Inc | 10,000 | 270.4K $ | |
| Zymeworks Inc | 10,000 | 250.4K $ | |
| LB Pharmaceuticals Inc | 10,000 | 246.6K $ | |
| Oruka Therapeutics Inc | 5,000 | 245.3K $ | |
| JASPER THERAPEUTICS INC | 276,312 | 242.1K $ | |